Figure 3
Figure 3. Treg reconstitution in a representative patient (UPN 301). Tregs were determined by flow and qRT-PCR analysis before and 30, 60, and 90 days after transplantation (Pre, d30, d60, d90, respectively); donor (Don) and the CD25-depleted lymphocyte product (SD). (A) Flow analysis for FOXP3 and CD25 in the CD4+ subset. Percentages displayed represent the fraction of positive cells in CD4+ cells. Two Treg populations, a CD25+ CD4+ FOXP3+ and a CD25− CD4+ FOXP3+ subset, could be identified before and after transplantation as well in the donor. The SD product was entirely CD25− but contained a CD25− CD4+ FOXP3+ subset of Tregs. CD25− CD4+ FOXP3+ and CD25+ CD4+ FOXP3+ Treg fractions increased after SCT. CD25+ CD4+ FOXP3− Teffs declined after SCT. (B) Total fraction of FOXP3+ cells in CD4+ cells. (C) Foxp3 mRNA expression in CD4-selected cells expressed as copy numbers per 1 × 106 copies of β-actin.

Treg reconstitution in a representative patient (UPN 301). Tregs were determined by flow and qRT-PCR analysis before and 30, 60, and 90 days after transplantation (Pre, d30, d60, d90, respectively); donor (Don) and the CD25-depleted lymphocyte product (SD). (A) Flow analysis for FOXP3 and CD25 in the CD4+ subset. Percentages displayed represent the fraction of positive cells in CD4+ cells. Two Treg populations, a CD25+ CD4+ FOXP3+ and a CD25 CD4+ FOXP3+ subset, could be identified before and after transplantation as well in the donor. The SD product was entirely CD25 but contained a CD25 CD4+ FOXP3+ subset of Tregs. CD25 CD4+ FOXP3+ and CD25+ CD4+ FOXP3+ Treg fractions increased after SCT. CD25+ CD4+ FOXP3 Teffs declined after SCT. (B) Total fraction of FOXP3+ cells in CD4+ cells. (C) Foxp3 mRNA expression in CD4-selected cells expressed as copy numbers per 1 × 106 copies of β-actin.

Close Modal

or Create an Account

Close Modal
Close Modal